Neuro Therapy Network Limited
To promote relief for people affected by multiple sclerosis and other neurological conditions through the representation of the member Centres and the provision of information, support and training.
Financial health, per its FY2024 accounts
The accounts state that the charity reported a net loss of £1,134 for the year ended 31 December 2024, resulting in total unrestricted reserves of £192,821. The independent examiner confirmed that accounting records were kept and accounts accorded with those records, with no matters causing concern. The trustees are satisfied the company is entitled to exemption from audit under the Companies Act 2006.
What the accounts disclose
Trustees
- Bernard Geoffrey Elwen
- Caroline Jane Blake-Symes
- Gideon David Schulman
- Howard Cheetham
- Mark Eric Suddes
- Stephen George Wilson
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £50k | £52k |
| 31/12/2023 | £29k | £74k |
| 31/12/2022 | £17k | £53k |
| 31/12/2021 | £31k | £59k |
| 31/12/2020 | £34k | £55k |
Common questions
Is Neuro Therapy Network Limited financially healthy?
Per its FY2024 accounts: The accounts state that the charity reported a net loss of £1,134 for the year ended 31 December 2024, resulting in total unrestricted reserves of £192,821. The independent examiner confirmed that accounting records were kept and accounts accorded with those records, with no matters causing concern. The trustees are satisfied the company is entitled to exemption from audit under the Companies Act 2006. Its FY2024 accounts were independently examined.
Who funds Neuro Therapy Network Limited?
Funders whose own accounts filings name Neuro Therapy Network Limited as a grant recipient include THE OFENHEIM CHARITABLE TRUST.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| THE OFENHEIM CHARITABLE TRUST | FY2023 | £12k | |
| THE OFENHEIM CHARITABLE TRUST | FY2022 | £9k | |
| THE OFENHEIM CHARITABLE TRUST | FY2025 | £5k |